Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesSS-31 (Elamipretide) & Longevity Biomarkers in 2026
SS-31 (Elamipretide) is often touted for its mitochondrial benefits. We scrutinise its influence on crucial longevity biomarkers, separating robust evidence from early signals.
PeptidesEpithalon After 50: Reversing Ageing Biomarkers
A deep dive into Epithalon's efficacy for individuals over 50, examining its impact on telomeres, sleep, and overall healthspan.
SupplementsRhodiola Rosea & Longevity Biomarkers:
We delve into Rhodiola Rosea's effects on crucial longevity biomarkers, analysing the evidence for its role in modulating inflammation, epigenetic age, and cellular health.
PeptidesPinealon: Cognitive Resilience Breakthroughs by
New research into Pinealon's effects on cognitive resilience, antioxidant defences, and neuronal gene expression, specifically clinical evidence from 2025-2026.
PeptidesIpamorelin's Biomarker Impact: Longevity
Could Ipamorelin influence key longevity biomarkers? We scrutinise its impact on IGF-1, inflammation, and cellular ageing, assessing the evidence for its role in healthspan.
PeptidesDihexa After 50: Reclaiming Cognitive Edge in
Dihexa, a potent hexapeptide derivative, offers intriguing prospects for cognitive support in adults over 50, targeting age-related declines in neuroplasticity. We examine its mechanisms, preclinical evidence, and considerations for its use.
PeptidesCJC-1295 and Longevity Biomarkers: Outlook for
CJC-1295 is a synthetic GHRH analogue. This deep-dive examines its documented and speculative effects on critical longevity biomarkers, offering a scientific perspective for 2026.
PeptidesPinealon and Longevity Biomarkers: What the
Pinealon, a tripeptide, is hypothesised to influence longevity pathways. We examine its potential effects on epigenetic clocks, inflammatory markers, and other key biomarkers.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.